Although alcoholic hepatitis (AH) is a relatively common life threatening liver disease, some controversy exists about its assessment. The most important two points are to assess the mortality risk and the decision to use corticosteroid and/or pentoxyfylline treatment. Several prognostic scores have been described regarding these two key factors.
The first score for AH, the discriminant function (DF) score, was described in 1978 and modified in 1989. The second score, the Glasgow AH (GAHS) score, was developed in 2005 and revealed that patients with GAHS ≥ 9 may benefit from treatment with corticosteroids. Thereafter, the Model for End-Stage Liver Disease (MELD) and age, bilirubin, International Normalized Ratio (INR) and creatinine (ABIC) scores have been presented to assess patients diagnosed with AH. Read More>>>>>>>>